Esperion Therapeutics

Esperion’s ‘lipid lurkers’ take on cardiovascular disease
Medical Marketing and Media
Tue, 07/16/24 - 12:04 pm
Esperion Therapeutics
Nexlizet
Nexletol
DTC advertising
Esperion Targets Seven-Fold Jump in Cholesterol Drug Population with FDA Label Expansion
BioSpace
Mon, 03/25/24 - 11:19 am
Esperion Therapeutics
cholesterol
Nexletol
Nexlizet
FDA
Cholesterol-focused Esperion loses appetite for oral PCSK9 collab with Serometrix
Fierce Biotech
Tue, 08/1/23 - 11:57 am
Esperion Therapeutics
R&D
Serometrixjm
PCSK9 inhibitors
cholesterol
Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit
Fierce Pharma
Tue, 03/28/23 - 10:57 pm
Esperion Therapeutics
Daiichi Sankyo
Nexletol
SEC
Daiichi torches Esperion’s Nexletol milestone promises
EP Vantage
Fri, 03/17/23 - 10:10 am
Daiichi Sankyo
Esperion Therapeutics
Nexletol
ACC 2023 – Esperion’s outcomes win looks lacklustre
EP Vantage
Mon, 03/6/23 - 10:45 am
Esperion Therapeutics
ACC
Nexletol
cholesterol
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
restructuring
Rigel Pharmaceuticals
Zymergen
Esperion Therapeutics
Amarin
Theravance
Sanofi
Acorda Therapeutics
CureVac
Ziopharm Oncology
Esperion gets out the budget ax, chopping 170 staffers as its big drug launch sputters
Endpoints
Mon, 10/18/21 - 11:12 am
Esperion Therapeutics
layoffs
FDA
Nexletol
bempadoic acid
What if a pill could lower cholesterol like pricey injectables? Esperion intends to find out
Stat
Wed, 01/13/21 - 10:36 am
Esperion Therapeutics
cholesterol
Serometrix
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
Xconomy
Wed, 02/26/20 - 11:21 pm
Esperion Therapeutics
FDA
bempedoic acid
Esperion shifts to show not tell
EP Vantage
Tue, 02/25/20 - 10:21 am
Esperion Therapeutics
bempedoic acid
Nexletol
Esperion adds more competition to cholesterol drug market with newly approved drug
BioPharma Dive
Fri, 02/21/20 - 11:57 pm
Esperion Therapeutics
cholesterol
bempedoic acid
FDA
Nexletol
Go or no go? Esperion's double whammy and a look to priority reviews
EP Vantage
Thu, 01/30/20 - 10:43 am
FDA
Esperion Therapeutics
Acacia Pharma
Blueprint Medicines
Agile Therapeutics
Lundbeck
Sun Pharma
Biohaven
Durect Corporation
Biotech's Most Volatile Binary Events for Q1
Motley Fool
Fri, 01/3/20 - 10:24 am
FDA
Esperion Therapeutics
Karyopharm
TG Therapeutics
Heron Therapeutics
Esperion's cholesterol-lowering drug clears test in diabetics
Fierce Biotech
Thu, 08/29/19 - 10:13 am
Esperion Therapeutics
type 2 diabetics
bempedoic acid
Eyeing a drug launch in early ’20, Esperion lines up a new, $200M funding deal
Endpoints
Fri, 06/28/19 - 12:29 pm
Esperion Therapeutics
bempadoic acid
drug launches
Here's Why Esperion Therapeutics Shares Rocketed 11.5% Higher Today
Motley Fool
Mon, 05/6/19 - 07:24 pm
Esperion Therapeutics
bempedoic acid
FDA
Esperion’s cholesterol-lowering pill works when statins fail
Pharmaforum
Thu, 03/14/19 - 09:56 am
Esperion Therapeutics
cholesterol
statins
bempedoic acid
Daiichi Sankyo lines up a $900M deal for rights to a cholesterol drug looking to disrupt a blockbuster market
Endpoints
Fri, 01/4/19 - 09:20 am
Daiichi Sankyo
Esperion Therapeutics

Pages